BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29966535)

  • 1. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
    Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
    Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
    Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
    Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
    Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2019 Jul; 8(1):62. PubMed ID: 31303174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
    Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
    Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the elimination of onchocerciasis.
    Thylefors B; Alleman M
    Ann Trop Med Parasitol; 2006 Dec; 100(8):733-46. PubMed ID: 17227651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final report of the Conference on the eradicability of Onchocerciasis.
    Dadzie Y; Neira M; Hopkins D
    Filaria J; 2003 Feb; 2(1):2. PubMed ID: 12605722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
    Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
    Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research for new drugs for elimination of onchocerciasis in Africa.
    Kuesel AC
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):272-286. PubMed ID: 27693536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
    Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
    Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
    Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
    Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
    Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
    Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.
    Nikièma AS; Koala L; Post RJ; Kima A; Compaoré J; Kafando CM; Nana JB; Bougouma C; Faye B; Traoré S; Dabiré RK
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012118. PubMed ID: 38683750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.